Skip to content

Zoetis ZTS Current Debt

Current Debt at other companies

Neogen logo
NeogenNEOG
$0-100%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$150M-12.2%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$22.83M+40.5%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$73M+65.9%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$7.13M+150%
Revvity logo
RevvityRVTY
$575.83M+237,847%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$30.13B-56.6%
Enterprise value$38.17B-48.9%
P/E11.4×-15.5×
P/S3.2×-4.2×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's current debt?
Zoetis (ZTS) reported current debt of $750M in Q1 2026.
How has Zoetis's current debt changed year-over-year?
Zoetis's current debt decreased by 44.4% year-over-year, from $1.35B to $750M.
What is the long-term trend for Zoetis's current debt?
Over 5 years (2020 to 2025), Zoetis's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $4M to $0.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.